Herbal Components for the Treatment of Alzheimer's Disease

被引:1
|
作者
Bisht, Tanu [1 ]
Sundram, Sonali [1 ]
Malviya, Rishabha [1 ]
Pandey, Akanksha [1 ]
机构
[1] Galgotias Univ, Sch Med & Allied Sci, Dept Pharm, Greater Noida, Uttar Pradesh, India
来源
NATURAL PRODUCTS JOURNAL | 2023年 / 13卷 / 07期
关键词
Alzheimer's disease; neuroprotection; NMDA receptor; herbal medicine; oxidative stress; neural degradation; TRANSGENIC MOUSE MODEL; AMYLOID-BETA-PEPTIDE; INDUCED COGNITIVE IMPAIRMENTS; GALACTOSE-INDUCED SENESCENCE; SCOPOLAMINE-INDUCED AMNESIA; CURCUMIN CURCUMA-LONGA; KOREAN RED GINSENG; INDUCED CELL-DEATH; CONVOLVULUS-PLURICAULIS; BACOPA-MONNIERA;
D O I
10.2174/2210315513666230123111541
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Globally, there are around 50 million Alzheimer's disease sufferers worldwide, a number that is expected to double every five years and reach 152 million by 2050. Traditional drugs for cognitive impairment are only palliative and do not cure the disease. Alzheimer's disease is characterised by memory and language loss, as well as difficulties with visual orientation and greater executive function. The present study aimed to examine various causes, mechanisms, and roles of different herbal components in the treatment of Alzheimer's disease. Since ancient times, several different plants have been utilised to improve memory and treat various dementia-related issues. These anti-AD plants include a wide taxonomic range due to acetyl choline esterase inhibition, antioxidant capacity, neuroprotection, mitochondrial energy restoration, and/or precipitated protein clearance. Secondary metabolites of these medicinal plants may be used to treat AD. AADvac1 is an active vaccination that stimulates an immune response by attacking numerous critical epitopes in pathogenic tau variants, thereby preventing tau aggregation and reducing the development of neurofibrillary tangles. Herbal plants are widely used because of their perceived effectiveness, safety, and low cost. To summarise, the evidence supporting the use of herbal components is promising, but more work is needed.
引用
收藏
页码:46 / 63
页数:18
相关论文
共 50 条
  • [41] Herbal Approaches for Alzheimer Disease: A Review
    Yoggeta
    Bhatia, Deepika
    Bhatti, Manisha
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (53B) : 311 - 324
  • [42] Aripiprazole in the treatment of Alzheimer's disease
    De Deyn, Peter Paul
    Drenth, Annemieke F. J.
    Kremer, Berry P.
    Voshaar, Richard C. Oude
    Van Dam, Debby
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (04) : 459 - 474
  • [43] Aducanumab for the treatment of Alzheimer?s disease
    Tagliapietra, Matteo
    DRUGS OF TODAY, 2022, 58 (10) : 465 - 477
  • [44] Interest in Alzheimer's Disease treatment
    Novella, Jean-Luc
    Morrone, Isabella
    Bertholon, Laurie-Anne
    Zylberberg, Marion
    Mahmoudi, Rachid
    GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT, 2012, 10 : 3 - 8
  • [45] Antidepressant treatment in Alzheimer's disease
    Brodaty, Henry
    LANCET, 2011, 378 (9789): : 375 - 376
  • [46] Idalopirdine as a treatment for Alzheimer's disease
    Galimberti, Daniela
    Scarpini, Elio
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (07) : 981 - 987
  • [47] Clioquinol for the treatment of Alzheimer's disease
    Jenagaratnam, L
    McShane, R
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (01):
  • [48] Anticholinesterases in the treatment of Alzheimer's disease
    Gandía, L
    Alvarez, RM
    Hernández-Guijo, JM
    González-Rubio, JM
    de Pascual, R
    Rojo, J
    Tapia, L
    REVISTA DE NEUROLOGIA, 2006, 42 (08) : 471 - 477
  • [49] Drugs for treatment of Alzheimer's disease
    Wilkinson, D
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2001, 55 (02) : 129 - 134
  • [50] Masitinib for the treatment of Alzheimer's disease
    Ettecho, Miren
    Cano, Amanda
    Sanchez-Lopez, Elena
    Verdaguer, Ester
    Folch, Jaume
    Auladell, Carme
    Camins, Antoni
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2021, 11 (04) : 263 - 276